Sagent, a leading provider of mortgage servicing technology, today announced the appointment of its board Chairman Chris ...

Sagent has appointed Chris Marshall as CEO to lead the implementation of its Dara platform. Marshall will succeed Geno Paluso ...

Sagent, a tech provider focused on mortgage servicing solutions, has appointed Board Chairman Chris Marshall as its new CEO.

Marshall is tasked with bringing Sagent's Dara servicing platform implementation up to scale, replacing Geno Paluso, who is ...

Sagent, a provider of mortgage servicing technology, has launched a new platform aimed at improving collaboration between mortgage servicers and their legal partners. The Dara Attorney Portal is ...

Sagent’s appointment of Marshall comes amid the company’s goals to deliver the mortgage servicing industry’s first cloud-native software platform this year. Marshall will work closely with Sagent’s ...

SCHAUMBURG, Ill., Dec. 3, 2025 /PRNewswire/ -- Sagent Pharmaceuticals ("Sagent"), a leading provider of injectables to the U.S. market, is excited to announce a strategic partnership with Provepharm ...

SCHAUMBURG, Ill., July 7, 2025 /PRNewswire/ -- Sagent Pharmaceuticals ("Sagent"), a leading provider of pharmaceuticals to the US market, and Qilu Pharmaceutical Co., Ltd. ("Qilu"), a leading ...

What investors should watch with fast-growing Sagent Pharmaceuticals. How does 146,443% growth in revenue over five years sound to you? To the folks at Sagent Pharmaceuticals (NASDAQ: SGNT), that ...

SCHAUMBURG, Ill., Aug. 18, 2011 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of vecuronium bromide for injection, a neuromuscular blocking agent, in 10 and ...